VistaGen Therapeutics, Inc.VistaGen Therapeutics, Inc.VistaGen Therapeutics, Inc.

VistaGen Therapeutics, Inc.

No trades
See on Supercharts

VTGN fundamentals

The current financial position of VistaGen Therapeutics, Inc.

Total assets of VTGN for Q3 23 is 131.07 M USD, 210.62% more than the previous Q2 23. And total liabilities increased by 18.82% in Q3 23 to 7.78 M USD.

Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
‪0.00‬
Total assets
Total liabilities
Currency: USD
Q1 '22
Q2 '22
Q3 '22
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Total assetsYoY growth
Total equityYoY growth